Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.67 |
| ▸ | MEN1 | O00255 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | SSTR1 | P30872 | 2/20 | 0.58 |
| ▸ | SSTR2 | P30874 | 2/20 | 0.58 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.58 |
| ▸ | SSTR3 | P32745 | 2/20 | 0.58 |
| ▸ | SSTR5 | P35346 | 2/20 | 0.58 |
| ▸ | TACR1 | P25103 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.52 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5231559 | 0.84 | TACR1 (0.49) | KMT2AMEN1MAPTTACR1L3MBTL1 | |
| SCHEMBL5229392 | 0.83 | KMT2A (0.49) | KMT2AMEN1MAPTSSTR1SSTR2 | |
| SCHEMBL5230507 | 0.81 | MAPT (0.43) | KMT2AMEN1MAPTSSTR1SSTR2 | |
| SCHEMBL5239008 | 0.80 | CLPP (0.42) | KMT2AMEN1MAPTSSTR1SSTR2 | |
| SCHEMBL5230347 | 0.80 | TACR1 (0.83) | KMT2AMEN1TACR1L3MBTL1HDAC1 | |
| SCHEMBL5229359 | 0.79 | TACR1 (0.53) | KMT2AMEN1MAPTSSTR1SSTR2 | |
| SCHEMBL7096617 | 0.79 | TACR1 (0.53) | KMT2AMEN1MAPTSSTR1SSTR2 | |
| SCHEMBL7094153 | 0.79 | L3MBTL1 (0.43) | KMT2AMEN1MAPTSSTR1SSTR2 | |
| SCHEMBL5229554 | 0.78 | TACR2 (0.43) | KMT2AMEN1MAPTSSTR1SSTR2 | |
| SCHEMBL5232940 | 0.78 | TACR2 (0.43) | KMT2AMEN1MAPTSSTR1SSTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6452001-B2 | 1,4-DIAZEPINE-2-ONE DERIVATIVES AS NEUROKININ ANTAGONIST | HOFFMANN-LA ROCHE INC. | 2002-09-17 | — | — | US | claimed |
| US-20020010174-A1 | Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation | F. HOFFMANN-LA ROCHE AG (CH) | 2002-01-24 | — | — | US | claimed |
| EP-1296961-B1 | 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2007-02-14 | — | — | EP | disclosed |
| US-6452001-B2 | 1,4-DIAZEPINE-2-ONE DERIVATIVES AS NEUROKININ ANTAGONIST | HOFFMANN-LA ROCHE INC. | 2002-09-17 | — | — | US | disclosed |
| US-20020010174-A1 | Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation | F. HOFFMANN-LA ROCHE AG (CH) | 2002-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010174-A1 | Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation | BDKRB2, NPSR1, BDKRB1 | KMT2A 1204/4885MEN1 687/4885MAPT 4885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.